Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany (2022) Mohr P, Scherrer E, Assaf C, Bender M, Berking C, Chandwani S, Eigentler T, et al. Journal article Mechanical thrombectomy for acute ischemic stroke in COVID-19 patients: multicenter experience in 111 cases (2022) Styczen H, Maus V, Goertz L, Koehrmann M, Kleinschnitz C, Fischer S, Moehlenbruch M, et al. Journal article The prognostic impact of Claudin 6 in papillary renal cell carcinoma (2022) Mikuteit M, Zschäbitz S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article cMET: a prognostic marker in papillary renal cell carcinoma? (2022) Erlmeier F, Bruecher B, Stoehr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article Towards a better treatment of patients with vascular malformations: certified interdisciplinary centers are mandatory* (2022) Cucuruz B, Koller M, Pfleiderer R, Geisthoff U, Meyer L, Kapp F, Lang W, et al. Journal article Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry (2022) Stoelzl D, Boraczynski N, Heratizadeh A, Haufe E, Harder I, Abraham S, Heinrich L, et al. Conference contribution S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS) (2022) Helbig D, Ziemer M, Dippel E, Erdmann M, Hillen U, Leiter U, Mentzel T, et al. Journal article S3-Leitlinie: Diagnostik und Therapie biliärer Karzinome (2022) Bitzer M, Voesch S, Albert J, Bartenstein P, Bechstein W, Blödt S, Brunner T, et al. Journal article S3 Guideline - Diagnosis and treatment of biliary carcinomas: Long version 2.0 - June 2021 - AWMF Register No.: 032-053OL S3-Leitlinie - Diagnostik und Therapie biliärer Karzinome (2022) Bitzer M, Voesch S, Albert J, Bartenstein P, Bechstein W, Blödt S, Brunner T, et al. Journal article Selection of patients with rectal cancer for neoadjuvant therapy using pre-therapeutic MRI-Results from OCUM trial (2022) Stelzner S, Ruppert R, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, et al. Journal article